Join us for an exclusive webinar exploring GemPharmatech’s ambitious Knockout All Project (KOAP), a large-scale initiative to systematically generate knockout (KO) and conditional knockout (cKO) mouse strains for all ~23,000 protein coding genes in the mouse genome. 

As a leader in genetically engineered mouse models and preclinical services, GemPharmatech is advancing biomedical research through high-throughput, highly efficient genome editing platforms that enable the production of over 6,000 novel strains annually. To date, the KOAP pipeline has successfully targeted more than 11,000 genes, providing an expansive resource for investigating disease mechanisms that span from oncology and autoimmunity, to metabolism, and genetic diseases.

In this session, Dr. Bingzhou Han will present the latest updates on GemPharmatech’s KOAP project, and showcase key disease models developed through this platform. 

Key points include: 

• Strategies for mouse genome modification 

• Knockout All Project scientific and operational roadmap

• Application of KO and cKO models across disease areas 

Do not miss this opportunity to gain insights into one of the world’s most comprehensive mouse genetics initiative and learn more about how it can support your research!

Time:

8:00 AM PDT | 10:00 AM CDT | 11:00 AM EDT | 5:00 PM CEST